Coe

Coe Corporation was an American multinational healthcare and biotechnology corporation that developed and manufactured electronic devices and machinery for the consumer, industrial, and medical markets. Founded in 1926 by Gwendolyn Coe with the merger of her late husbands four companies, Coe emerged active in several fields of the electronics industry.

Following several high-profile acquisitions of leading medical device manufacturers, Coe established dominance in the field of biotechnology in the mid 1990s, developing the first reliable biochemical sensor implants, which were utilized in their Cybocare line of robotic prosthetics, some of the first to be approved by the FDA, as well as by a range of non-prosthetic implants ranging from the BioKey to the Personal Ocular Menu.

The Ross Corporation owns a significant stake in Coe at 21%, followed by GreenPage at 15.6% and Inky&Peters at 13%.